Implementation of ISBT 128, a quality system, a standardized bar code labeling of blood products worldwide, electronic transfusion pathway: four years of experience in Norway-Reference-Cited by-同舟云学术

Implementation of ISBT 128, a quality system, a standardized bar code labeling of blood products worldwide, electronic transfusion pathway: four years of experience in Norway

Published:2007-09 Issue:9 Volume:47 Page:1674-1678
ISSN:0041-1132
Container-title:Transfusion
language:en
Short-container-title:Transfusion

Author:

Aandahl Gerd Selset,Knutsen Teresa Risopatron,Nafstad Kjersti

Publisher

Wiley

Subject

Hematology,Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1537-2995.2007.01340.x/fullpdf

Reference6 articles.

1. 1. ISBT 128 standard. Technical Specification Version 2.0.0.York (PA): ICCBA, Inc.; 2003 .

2. 2. United States industry consensus standard for the uniform labeling of blood and blood components using ISBT 128 [monograph on the Internet]. Version 1.2.0.York (PA): The International Council for Commonality in Blood Banking Automation, Inc; 1999 . Available from: http://www.bloodct.org/industry_consensus_standard.pdf

3. 3. HPC (hematopoetic progenitor cells) and T-cells: US labeling instructions. Version 2.0.0.York (PA): ICCBBA, Inc.; 2001 Aug.

4. 4. A technical bulletin in support of ISBT 128: specification for ISBT-128 data structures to support the secure bedside matching of patient and transfusion/transplant product identification [monograph on the Internet]. Version 2.0.0.York (PA): ICCBBA, Inc.; 2006 .

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Implementation of an international barcode labeling standard, International Society of Blood Transfusion 128, and its integration with local regulations at a blood center in India: Step-by-step journey;Asian Journal of Transfusion Science;2023-05-11

2. Effects of convalescent plasma infusion on the ADAMTS13-von Willebrand factor axis and endothelial integrity in patients with severe and critical COVID-19;Research and Practice in Thrombosis and Haemostasis;2023-01

3. Effect of convalescent plasma as complementary treatment in patients with moderate COVID ‐19 infection;Transfusion Medicine;2022-01-09

4. Blood Bank Inventory;Immunohematology and Blood banking;2020

5. Improving Turnaround Times through a Process Improvement Initiative Involving Barcoding, Floorplans, Dual Measuring Cells, Chemistry Analyzers, and Staff Shifts;The Journal of Applied Laboratory Medicine;2019-04-17